Case Study – December 2022
Our patient case study specially curated for you by our Faculty Member, Prof. Samer Ellahham on concerns about statin associated Diabetes Mellitus.
Santos RD, Ruzza A, Hovingh GK, et al.Journal:
Lancet Diabetes Endocrinol
First published: October 1, 2022 DOI: 10.1016/S2213-8587(22)00221-2
Case Study: RS is a 64-year-old Male having dyslipidemia.
BP 144/87 mm Hg
Low-density lipoprotein cholesterol (LDL-C) 112 mg/dL
High-density lipoprotein cholesterol (HDL-C) of 47 mg/dL
Triglycerides 190 mg/dL
(-) tobacco, (-) alcohol
Body mass index (BMI) 33 kg/m2
Valsartan 80 mg/d
Father developed type 2 diabetes mellitus (T2DM) and ASCVD at age 58
Fasting blood glucose 103 mg/dL
Serum Creatinine 1.1 mg/dL
Urinary analysis within normal limits
RS reports that he is reluctant to take statins as they cause diabetes especially with his family history.